Key molecular dynamic could boost cancer treatments while limiting stem cell transplant rejection

A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell ...

Living longer with less burden of cancer treatment: New endpoints defined for cancer trials

An international group of experts led by the Comprehensive Cancer Center (CCC) at MedUni Vienna and University Hospital ...

Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers

Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating ...
Medscape

Wildfire Smoke Linked to Potential Risks for Some Cancers

An analysis of the PLCO Cancer Screening Trial detected linear dose-response relationships between wildfire smoke exposure and risks for hematopoietic, bladder, breast, colorectal, and lung cancer.
Frontiers

Immunotherapy and novel combination strategies in metastatic colorectal cancer: overcoming resistance and expanding treatment opportunities

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer-related mortality worldwide. While significant advances have been achieved with ...
American Council on Science and Health

The Curious Case of Methylene Blue

Born as a coal-tar dye, reborn as a “magic bullet,” methylene blue has taken an improbable journey from textile vats to today ...
The Lancet

War in the Middle East: collateral damage

A month after the USA and Israel launched attacks on Iran, Iran and the USA agreed to a conditional 2-week ceasefire on April 8, 2026. However, strikes continued in Lebanon, and after peace talks ...